content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001992908</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001885522</issuerCik>
        <issuerName>Neumora Therapeutics, Inc.</issuerName>
        <secFileNumber>001-41802</secFileNumber>
        <issuerAddress>
          <com:street1>490 ARSENAL WAY, SUITE 200</com:street1>
          <com:city>WATERTOWN</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02472</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>(857) 760-0900</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Lenz Robert A.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Officer</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common stock</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Merrill Lynch</name>
          <address>
            <com:street1>225 Liberty Street</com:street1>
            <com:street2>Floor 37</com:street2>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10281</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>10676</noOfUnitsSold>
        <aggregateMarketValue>129090.97</aggregateMarketValue>
        <noOfUnitsOutstanding>160027746</noOfUnitsOutstanding>
        <approxSaleDate>09/18/2024</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common stock</securitiesClassTitle>
        <acquiredDate>09/11/2024</acquiredDate>
        <natureOfAcquisitionTransaction>Vesting of restricted stock unit award</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Neumora Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>10676</amountOfSecuritiesAcquired>
        <paymentDate>09/11/2024</paymentDate>
        <natureOfPayment>Granted as part of issuer equity compensation plan</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name>Robert Lenz</name>
          <address>
            <com:street1>490 ARSENAL WAY</com:street1>
            <com:street2>SUITE 200</com:street2>
            <com:city>WATERTOWN</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02472</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common stock</securitiesClassTitle>
        <saleDate>09/12/2024</saleDate>
        <amountOfSecuritiesSold>32948</amountOfSecuritiesSold>
        <grossProceeds>376664.61</grossProceeds>
      </securitiesSoldInPast3Months>
      <securitiesSoldInPast3Months>
        <sellerDetails>
          <name> Robert Lenz</name>
          <address>
            <com:street1>490 ARSENAL WAY</com:street1>
            <com:street2>SUITE 200</com:street2>
            <com:city>WATERTOWN</com:city>
            <com:stateOrCountry>MA</com:stateOrCountry>
            <com:zipCode>02472</com:zipCode>
          </address>
        </sellerDetails>
        <securitiesClassTitle>Common stock</securitiesClassTitle>
        <saleDate>09/17/2024</saleDate>
        <amountOfSecuritiesSold>30788</amountOfSecuritiesSold>
        <grossProceeds>363734.12</grossProceeds>
      </securitiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>09/18/2024</noticeDate>
        <planAdoptionDates>
          <planAdoptionDate>06/12/2024</planAdoptionDate>
        </planAdoptionDates>
        <signature>Robert Lenz</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 4219}]
text: 144
  0001992908
  XXXXXXXX
  LIVE
  0001885522
  Neumora Therapeutics, Inc.
  001-41802
  490 ARSENAL WAY, SUITE 200
  WATERTOWN
  MA
  02472
  (857) 760-0900
  Lenz Robert A.
  Officer
  Common stock
  Merrill Lynch
  225 Liberty Street
  Floor 37
  New York
  NY
  10281
  10676
  129090.97
  160027746
  09/18/2024
  NASDAQ
  Common stock
  09/11/2024
  Vesting of restricted stock unit award
  Neumora Therapeutics, Inc.
  N
  10676
  09/11/2024
  Granted as part of issuer equity compensation plan
  N
  Robert Lenz
  490 ARSENAL WAY
  SUITE 200
  WATERTOWN
  MA
  02472
  Common stock
  09/12/2024
  32948
  376664.61
  Robert Lenz
  490 ARSENAL WAY
  SUITE 200
  WATERTOWN
  MA
  02472
  Common stock
  09/17/2024
  30788
  363734.12
  09/18/2024
  06/12/2024
  Robert Lenz